Genmab — Oktober 2018
-
God morgen
-
God morgen.
-
God morgen
-
åh nej - Peter Aabo var en behagelig og vidende mand. Altid klar på en god debat. Det er en virkelig tab
-
@JStudsgaard good question
it is a safety/ dose escalation study, if anything is really wrong with safety, they will stop it anyway, immidiately. Maybe they now think they will already have enough info by 2019. Or they recruited very fast. What botters me a bit that not all centers started recruiting yet, some even withdrawn. Are they not interested? Can they not get the patients interested? Or vice versa; did the other centers get recruited so fast they have enough? -
Genmab at ESMO
https://twitter.com/GenmabR_D/status/1053166108088377344
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind